Appetite is biology. So is the plan.
Bring appetite, weight, glucose, medication history, and the long view into one clinical conversation. The right treatment depends on your case, not a one-size-fits-all pathway.
Treatments in this collection
Semaglutide
A clinician on the other end of every dose.
Compounded semaglutide injection with clinician review, pharmacy fulfillment, shipping, and follow-up inside one care model. (Contains semaglutide.)
Tirzepatide
Two incretin pathways. One physician watching both.
Compounded tirzepatide injection built around dual GIP and GLP-1 receptor biology with clinician-directed dosing and follow-up. (Contains tirzepatide.)
Semaglutide + B12 Microdose
A lower-dose path with B12 built in.
A lower-dose compounded semaglutide and B12 prescription for clinician-guided metabolic care at a different starting scale. (Contains semaglutide and vitamin B12.)
Tirzepatide + B12 Microdose
Dual-pathway biology at a lower starting scale.
A lower-dose compounded tirzepatide and B12 prescription that keeps dual-receptor biology inside clinician-led care. (Contains tirzepatide and vitamin B12.)
Semaglutide ODT
A needle-free route, chosen by clinical determination.
A clinician-selected compounded semaglutide ODT for patients whose individual medical needs support a dissolving oral route. (Contains semaglutide.)
Tirzepatide ODT
A daily dissolving route, considered clinically.
A clinician-selected compounded tirzepatide ODT with daily dissolving administration and route-specific prescribing. (Contains tirzepatide.)
Metformin ER
Diabetes made it famous. Longevity made it interesting again.
FDA-approved generic metformin ER with decades of metabolic use and a serious place in the longevity conversation.
Lipo-C
Four named ingredients. Nothing proprietary.
A transparent compounded injection with methionine, inositol, choline, and vitamin B12, prescribed as a supporting part of a clinician-directed metabolic plan.
Tesamorelin
Visceral fat is the specific target studied.
Compounded tesamorelin centered on the molecule's studied visceral-fat pathway and the medical oversight it deserves.